Skip to content

Clinical trials

Neoplasms by Site trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: United States Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20072
20095
20107
20119
20122
20133
20149
20153
20166
20177
20186
20199
20205
202110
20226
202312
20242
202512
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting30
Terminated24
Active, not recruiting12
Unknown status6
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exact Sciences Corporation6
Revolution Medicines, Inc.6
Eli Lilly and Company5
AstraZeneca4
Blueprint Medicines Corporation4
Sumitomo Pharma America, Inc.4
Bristol-Myers Squibb3
Hoffmann-La Roche3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
VA Office of Research and Development3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site119
Neoplasms111
Digestive System Neoplasms31
Lung Neoplasms31
Digestive System Diseases30
Carcinoma28
Carcinoma, Non-Small-Cell Lung27
Neoplasms by Histologic Type27
Thoracic Neoplasms27
Gastrointestinal Neoplasms26

Trials

Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.